In-depth researches showed that CD10+GPR77+ CAFs may correlate with chemoresistance in breast cancer and lung cancer [34]; PDGFRα negative CAFs may correlate with poor prognosis in breast cancer [36]. This evidence concerns the gene MME and lung cancer.